Benylan Mixtúra, lausn 2,8 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

benylan mixtúra, lausn 2,8 mg/ml

mcneil denmark aps - diphenhydraminum hýdróklóríð - mixtúra, lausn - 2,8 mg/ml

Betnovat Húðlausn 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

betnovat húðlausn 1 mg/ml

glaxosmithkline pharma a/s - betamethasonum valerat - húðlausn - 1 mg/ml

Dermovat Húðlausn 0,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

dermovat húðlausn 0,5 mg/ml

glaxosmithkline pharma a/s - clobetasolum própíónat - húðlausn - 0,5 mg/ml

Ventoline (Ventolin Diskos) Innöndunarduft 200 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ventoline (ventolin diskos) innöndunarduft 200 míkróg/skammt

glaxosmithkline pharma a/s - salbutamolum súlfat - innöndunarduft - 200 míkróg/skammt

Voltaren Hlaup 11,6 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

voltaren hlaup 11,6 mg/g

haleon denmark aps - diclofenacum tvíetýlamín - hlaup - 11,6 mg/g

Hyftor Evrópusambandið - íslenska - EMA (European Medicines Agency)

hyftor

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.